WHO ANNOUNCES PHARMACEUTICAL COMPANIES AGREE TO STOP MARKETING SINGLE-DRUG ARTEMISININ MALARIA PILLS

The World Health Organization (WHO) announced today that 13 pharmaceutical companies have agreed to comply with WHO's recommendation to phase out single-drug artemisinin medicines for oral treatment of malaria. This group includes the main producers of high quality artemisinin monotherapies. The companies will now focus their marketing efforts for malaria primarily on Artemisinin Combination Therapies (ACTs), in line with WHO recommendations.

Noticias.info (http://www.noticias.info/asp/aspComunicados.asp?nid=177528&src=0)